<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR47">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Winkelmann</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Loebermann</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Reisinger</surname>
    <given-names>EC</given-names>
   </name>
   <name>
    <surname>Hartung</surname>
    <given-names>HP</given-names>
   </name>
   <name>
    <surname>Zettl</surname>
    <given-names>UK</given-names>
   </name>
  </person-group>
  <article-title>Disease-modifying therapies and infectious risks in multiple sclerosis</article-title>
  <source>Nat Rev Neurol</source>
  <year>2016</year>
  <volume>12</volume>
  <issue>4</issue>
  <fpage>217</fpage>
  <lpage>233</lpage>
  <?supplied-pmid 26943779?>
  <pub-id pub-id-type="pmid">26943779</pub-id>
 </element-citation>
</ref>
